Cargando…

Metallothionein 2A (MT2A) controls cell proliferation and liver metastasis by controlling the MST1/LATS2/YAP1 signaling pathway in colorectal cancer

BACKGROUND: Colorectal cancer (CRC) is one of the three major cancers in the world and is the cancer with the most liver metastasis. The present study aimed to investigate the role of metallothionein 2A (MT2A) in the modulation of CRC cell proliferation and liver metastasis, as well as its molecular...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xi, Quan, Jun, Shen, Zhaolong, Zhang, Zequn, Chen, Zhijian, Li, Liang, Li, Xiaorong, Hu, Gui, Deng, Xiaofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9158144/
https://www.ncbi.nlm.nih.gov/pubmed/35642057
http://dx.doi.org/10.1186/s12935-022-02623-w
_version_ 1784718776234672128
author Liu, Xi
Quan, Jun
Shen, Zhaolong
Zhang, Zequn
Chen, Zhijian
Li, Liang
Li, Xiaorong
Hu, Gui
Deng, Xiaofeng
author_facet Liu, Xi
Quan, Jun
Shen, Zhaolong
Zhang, Zequn
Chen, Zhijian
Li, Liang
Li, Xiaorong
Hu, Gui
Deng, Xiaofeng
author_sort Liu, Xi
collection PubMed
description BACKGROUND: Colorectal cancer (CRC) is one of the three major cancers in the world and is the cancer with the most liver metastasis. The present study aimed to investigate the role of metallothionein 2A (MT2A) in the modulation of CRC cell proliferation and liver metastasis, as well as its molecular mechanisms. METHODS: The expression profile of metallothionein 2A (MT2A) in colorectal cancer retrieved from TCGA, GEO and Oncomine database. The biological effect of MT2A overexpression was investigated mainly involving cell proliferation and migration in CRC cells as well as growth and metastasis in CRC animal models. To explore the specific mechanism of MT2A metastasis in CRC, transcriptome sequencing was used to compare the overall expression difference between the control group and the MT2A overexpression group. RESULTS: Metallothionein 2A (MT2A) was downregulated in the tumor tissues of patients with CRC compared to adjacent normal tissues and was related to the tumor M stage of patients. MT2A overexpression inhibited CRC cell proliferation and migration in cells, as well as growth and metastasis in CRC animal models. While knockdown of MT2A had the opposite effect in cells. Western blotting confirmed that MT2A overexpression promoted the phosphorylation of MST1, LAST2 and YAP1, thereby inhibiting the Hippo signaling pathway. Additionally, specific inhibitors of MST1/2 inhibited MT2A overexpression-mediated phosphorylation and relieved the inhibition of the Hippo signaling pathway, thus promoting cell proliferation. Immunohistochemistry in subcutaneous grafts and liver metastases further confirmed this result. CONCLUSIONS: Our results suggested that MT2A is involved in CRC growth and liver metastasis. Therefore, MT2A and MST1 may be potential therapeutic targets for patients with CRC, especially those with liver metastases. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-022-02623-w.
format Online
Article
Text
id pubmed-9158144
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-91581442022-06-02 Metallothionein 2A (MT2A) controls cell proliferation and liver metastasis by controlling the MST1/LATS2/YAP1 signaling pathway in colorectal cancer Liu, Xi Quan, Jun Shen, Zhaolong Zhang, Zequn Chen, Zhijian Li, Liang Li, Xiaorong Hu, Gui Deng, Xiaofeng Cancer Cell Int Research BACKGROUND: Colorectal cancer (CRC) is one of the three major cancers in the world and is the cancer with the most liver metastasis. The present study aimed to investigate the role of metallothionein 2A (MT2A) in the modulation of CRC cell proliferation and liver metastasis, as well as its molecular mechanisms. METHODS: The expression profile of metallothionein 2A (MT2A) in colorectal cancer retrieved from TCGA, GEO and Oncomine database. The biological effect of MT2A overexpression was investigated mainly involving cell proliferation and migration in CRC cells as well as growth and metastasis in CRC animal models. To explore the specific mechanism of MT2A metastasis in CRC, transcriptome sequencing was used to compare the overall expression difference between the control group and the MT2A overexpression group. RESULTS: Metallothionein 2A (MT2A) was downregulated in the tumor tissues of patients with CRC compared to adjacent normal tissues and was related to the tumor M stage of patients. MT2A overexpression inhibited CRC cell proliferation and migration in cells, as well as growth and metastasis in CRC animal models. While knockdown of MT2A had the opposite effect in cells. Western blotting confirmed that MT2A overexpression promoted the phosphorylation of MST1, LAST2 and YAP1, thereby inhibiting the Hippo signaling pathway. Additionally, specific inhibitors of MST1/2 inhibited MT2A overexpression-mediated phosphorylation and relieved the inhibition of the Hippo signaling pathway, thus promoting cell proliferation. Immunohistochemistry in subcutaneous grafts and liver metastases further confirmed this result. CONCLUSIONS: Our results suggested that MT2A is involved in CRC growth and liver metastasis. Therefore, MT2A and MST1 may be potential therapeutic targets for patients with CRC, especially those with liver metastases. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-022-02623-w. BioMed Central 2022-05-31 /pmc/articles/PMC9158144/ /pubmed/35642057 http://dx.doi.org/10.1186/s12935-022-02623-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Liu, Xi
Quan, Jun
Shen, Zhaolong
Zhang, Zequn
Chen, Zhijian
Li, Liang
Li, Xiaorong
Hu, Gui
Deng, Xiaofeng
Metallothionein 2A (MT2A) controls cell proliferation and liver metastasis by controlling the MST1/LATS2/YAP1 signaling pathway in colorectal cancer
title Metallothionein 2A (MT2A) controls cell proliferation and liver metastasis by controlling the MST1/LATS2/YAP1 signaling pathway in colorectal cancer
title_full Metallothionein 2A (MT2A) controls cell proliferation and liver metastasis by controlling the MST1/LATS2/YAP1 signaling pathway in colorectal cancer
title_fullStr Metallothionein 2A (MT2A) controls cell proliferation and liver metastasis by controlling the MST1/LATS2/YAP1 signaling pathway in colorectal cancer
title_full_unstemmed Metallothionein 2A (MT2A) controls cell proliferation and liver metastasis by controlling the MST1/LATS2/YAP1 signaling pathway in colorectal cancer
title_short Metallothionein 2A (MT2A) controls cell proliferation and liver metastasis by controlling the MST1/LATS2/YAP1 signaling pathway in colorectal cancer
title_sort metallothionein 2a (mt2a) controls cell proliferation and liver metastasis by controlling the mst1/lats2/yap1 signaling pathway in colorectal cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9158144/
https://www.ncbi.nlm.nih.gov/pubmed/35642057
http://dx.doi.org/10.1186/s12935-022-02623-w
work_keys_str_mv AT liuxi metallothionein2amt2acontrolscellproliferationandlivermetastasisbycontrollingthemst1lats2yap1signalingpathwayincolorectalcancer
AT quanjun metallothionein2amt2acontrolscellproliferationandlivermetastasisbycontrollingthemst1lats2yap1signalingpathwayincolorectalcancer
AT shenzhaolong metallothionein2amt2acontrolscellproliferationandlivermetastasisbycontrollingthemst1lats2yap1signalingpathwayincolorectalcancer
AT zhangzequn metallothionein2amt2acontrolscellproliferationandlivermetastasisbycontrollingthemst1lats2yap1signalingpathwayincolorectalcancer
AT chenzhijian metallothionein2amt2acontrolscellproliferationandlivermetastasisbycontrollingthemst1lats2yap1signalingpathwayincolorectalcancer
AT liliang metallothionein2amt2acontrolscellproliferationandlivermetastasisbycontrollingthemst1lats2yap1signalingpathwayincolorectalcancer
AT lixiaorong metallothionein2amt2acontrolscellproliferationandlivermetastasisbycontrollingthemst1lats2yap1signalingpathwayincolorectalcancer
AT hugui metallothionein2amt2acontrolscellproliferationandlivermetastasisbycontrollingthemst1lats2yap1signalingpathwayincolorectalcancer
AT dengxiaofeng metallothionein2amt2acontrolscellproliferationandlivermetastasisbycontrollingthemst1lats2yap1signalingpathwayincolorectalcancer